Oct 20 (Reuters) - Dri Healthcare Trust:
* DRI HEALTHCARE TRUST ANNOUNCES ACQUISITION OF A SYNTHETIC
ROYALTY INTEREST IN THE U.S. SALES OF VELIGROTUG AND VRDN-003
FOR THE TREATMENT OF THYROID EYE DISEASE (TED)
* DRI HEALTHCARE TRUST - TO PAY $55 MILLION UPFRONT, $300
MILLION
TOTAL INVESTMENT
Source text:
Further company coverage: